vincaleukoblastine - Ontology Report

Help | FTP Download | Citing RGD | Contact Us

Keyword

ONTOLOGY REPORT - ANNOTATIONS

Term:	vincaleukoblastine	go back to main search page
Accession:	CHEBI:27375	browse the term
Definition:	A vinca alkaloid that has formula C46H58N4O9.
Synonyms:	related_synonym:	(2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE; C46H58N4O9; InChI=1S/C46H58N4O9/c1-8-42(54)23-28-24-45(40(52)57-6,36-30(15-19-49(25-28)26-42)29-13-10-11-14-33(29)47-36)32-21-31-34(22-35(32)56-5)48(4)38-44(31)17-20-50-18-12-16-43(9-2,37(44)50)39(59-27(3)51)46(38,55)41(53)58-7/h10-14,16,21-22,28,37-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3/t28-,37+,38-,39-,42+,43-,44-,45+,46+/m1/s1; InChIKey=JXLYSJRDGCGARV-XQKSVPLYSA-N; VLB; Vinblastine; [H][C@@]12N3CC[C@@]11c4cc(c(OC)cc4N(C)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC)[C@]1(C[C@@H]2CN(CCc3c1[nH]c1ccccc31)C[C@](O)(CC)C2)C(=O)OC
	alt_id:	CHEBI:27287; CHEBI:46447; CHEBI:9983
	xref_casrn:	865-21-4
	xref:	Beilstein:4779207 "Beilstein Registry Number"; ChEMBL:128853 "ChEMBL COMPOUND"; ChemIDplus:865-21-4 "CAS Registry Number"; DrugBank:DB00570 "DrugBank"; KEGG COMPOUND:865-21-4 "CAS Registry Number"; KEGG COMPOUND:C07201 "KEGG COMPOUND"
	xref_mesh:	MESH:D014747
	xref:	PDBeChem:VLB "PDBeChem"

Rat
Mouse
Human
All
show annotations for term's descendants
Sort by:

vincaleukoblastine
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		affects uptake	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		increases transport	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		decreases response to substance	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		multiple interactions	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		multiple interactions	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		multiple interactions	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		multiple interactions	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		multiple interactions	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		increases expression	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		decreases response to substance	ISO	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		decreases response to substance	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		decreases response to substance	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		increases transport	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		multiple interactions	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		decreases response to substance	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		multiple interactions	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		increases transport	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		increases activity	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		multiple interactions	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		increases secretion	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		decreases response to substance	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		decreases response to substance	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		decreases response to substance	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		multiple interactions	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11		decreases uptake	ISO	2	169,779,449	169,887,833	RGD:6480464	CTD
G	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11		increases export	ISO	2	169,779,449	169,887,833	RGD:6480464	CTD
G	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1		affects response to substance	EXP	16	16,043,434	16,236,931	RGD:6480464	CTD
G	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1		decreases response to substance	EXP	16	16,043,434	16,236,931	RGD:6480464	CTD
G	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1		decreases response to substance	ISO	16	16,043,434	16,236,931	RGD:6480464	CTD
G	ABCC2	ATP-binding cassette, sub-family C (CFTR/MRP), member 2		affects transport	EXP	10	101,542,463	101,611,662	RGD:6480464	CTD
G	ABCC2	ATP-binding cassette, sub-family C (CFTR/MRP), member 2		multiple interactions	EXP	10	101,542,463	101,611,662	RGD:6480464	CTD
G	ABCC2	ATP-binding cassette, sub-family C (CFTR/MRP), member 2		decreases response to substance	ISO	10	101,542,463	101,611,662	RGD:6480464	CTD
G	ABCC2	ATP-binding cassette, sub-family C (CFTR/MRP), member 2		affects transport	EXP	10	101,542,463	101,611,662	RGD:6480464	CTD
G	ABLIM1	actin binding LIM protein 1		affects response to substance	EXP	10	116,190,869	116,444,414	RGD:6480464	CTD
G	ACAT2	acetyl-CoA acetyltransferase 2		affects response to substance	EXP	6	160,182,989	160,200,087	RGD:6480464	CTD
G	ACOT13	acyl-CoA thioesterase 13		affects response to substance	EXP	6	24,667,263	24,705,297	RGD:6480464	CTD
G	ACP1	acid phosphatase 1, soluble		affects response to substance	EXP	2	264,869	278,283	RGD:6480464	CTD
G	ADD3	adducin 3 (gamma)		affects response to substance	EXP	10	111,765,726	111,895,323	RGD:6480464	CTD
G	AIF1	allograft inflammatory factor 1		decreases expression	ISO	6	31,582,994	31,584,798	RGD:6480464	CTD
G	AK1	adenylate kinase 1		decreases expression	ISO	9	130,628,759	130,640,022	RGD:6480464	CTD
G	AOX1	aldehyde oxidase 1		affects response to substance	EXP	2	201,450,731	201,536,218	RGD:6480464	CTD
G	APLN	apelin		decreases expression	ISO	X	128,779,236	128,788,933	RGD:6480464	CTD
G	APOBEC3C	apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C		affects response to substance	EXP	22	39,410,265	39,414,843	RGD:6480464	CTD
G	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E		affects response to substance	EXP	4	666,225	668,127	RGD:6480464	CTD
G	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2		affects response to substance	EXP	7	99,055,784	99,063,824	RGD:6480464	CTD
G	AURKB	aurora kinase B		affects response to substance	EXP	17	8,108,049	8,113,944	RGD:6480464	CTD
G	AXL	AXL receptor tyrosine kinase		affects response to substance	EXP	19	41,725,108	41,767,671	RGD:6480464	CTD
G	BIRC2	baculoviral IAP repeat containing 2		affects response to substance	EXP	11	102,217,913	102,249,401	RGD:6480464	CTD
G	BIRC3	baculoviral IAP repeat containing 3		affects response to substance	EXP	11	102,188,181	102,210,134	RGD:6480464	CTD
G	BIRC7	baculoviral IAP repeat containing 7		decreases response to substance	EXP	20	61,867,276	61,871,854	RGD:6480464	CTD
G	BUB1	BUB1 mitotic checkpoint serine/threonine kinase		affects response to substance	EXP	2	111,395,409	111,435,684	RGD:6480464	CTD
G	C5orf15	chromosome 5 open reading frame 15		affects response to substance	EXP	5	133,291,198	133,304,406	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		increases cleavage	ISO	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CAT	catalase		affects response to substance	EXP	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CCL2	chemokine (C-C motif) ligand 2		increases expression	ISO	17	32,582,296	32,584,222	RGD:6480464	CTD
G	CCNB1	cyclin B1		affects response to substance	EXP	5	68,462,837	68,474,072	RGD:6480464	CTD
G	CCNB1	cyclin B1		increases response to substance	EXP	5	68,462,837	68,474,072	RGD:6480464	CTD
G	CCNB2	cyclin B2		affects response to substance	EXP	15	59,397,284	59,417,244	RGD:6480464	CTD
G	CD14	CD14 molecule		increases expression	ISO	5	140,011,313	140,013,286	RGD:6480464	CTD
G	CD40LG	CD40 ligand		decreases response to substance	EXP	X	135,730,336	135,742,549	RGD:6480464	CTD
G	CD40LG	CD40 ligand		multiple interactions	EXP	X	135,730,336	135,742,549	RGD:6480464	CTD
G	CD44	CD44 molecule (Indian blood group)		increases expression	ISO	11	35,160,417	35,253,949	RGD:6480464	CTD
G	CDCA8	cell division cycle associated 8		affects response to substance	EXP	1	38,158,073	38,175,391	RGD:6480464	CTD
G	CDK2	cyclin-dependent kinase 2		affects response to substance	EXP	12	56,360,556	56,366,568	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		increases expression	ISO	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN2C	cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)		affects response to substance	EXP	1	51,434,367	51,440,309	RGD:6480464	CTD
G	CDKN3	cyclin-dependent kinase inhibitor 3		decreases expression	ISO	14	54,863,673	54,886,936	RGD:6480464	CTD
G	CDKN3	cyclin-dependent kinase inhibitor 3		decreases expression	ISO	14	54,863,673	54,886,936	RGD:6480464	CTD
G	CENPA	centromere protein A		affects response to substance	EXP	2	27,008,882	27,017,457	RGD:6480464	CTD
G	CKAP2	cytoskeleton associated protein 2		affects response to substance	EXP	13	53,029,495	53,050,763	RGD:6480464	CTD
G	COX17	COX17 cytochrome c oxidase copper chaperone		affects response to substance	EXP	3	119,388,372	119,396,243	RGD:6480464	CTD
G	COX5A	cytochrome c oxidase subunit Va		affects response to substance	EXP	15	75,212,616	75,230,495	RGD:6480464	CTD
G	COX6B1	cytochrome c oxidase subunit VIb polypeptide 1 (ubiquitous)		affects response to substance	EXP	19	36,139,125	36,149,686	RGD:6480464	CTD
G	CP	ceruloplasmin (ferroxidase)		increases expression	ISO	3	148,880,197	148,939,832	RGD:6480464	CTD
G	CREG1	cellular repressor of E1A-stimulated genes 1		affects response to substance	EXP	1	167,510,250	167,523,056	RGD:6480464	CTD
G	CRIPT	cysteine-rich PDZ-binding protein		affects response to substance	EXP	2	46,844,325	46,852,881	RGD:6480464	CTD
G	CTGF	connective tissue growth factor		affects response to substance	EXP	6	132,269,316	132,272,518	RGD:6480464	CTD
G	CTSS	cathepsin S		increases expression	ISO	1	150,702,672	150,738,433	RGD:6480464	CTD
G	CXCL5	chemokine (C-X-C motif) ligand 5		affects response to substance	EXP	4	74,861,359	74,864,416	RGD:6480464	CTD
G	CYP1A1	cytochrome P450, family 1, subfamily A, polypeptide 1		multiple interactions	ISO	15	75,011,883	75,017,877	RGD:6480464	CTD
G	DCPS	decapping enzyme, scavenger		affects response to substance	EXP	11	126,173,647	126,215,644	RGD:6480464	CTD
G	DDX23	DEAD (Asp-Glu-Ala-Asp) box polypeptide 23		affects response to substance	EXP	12	49,223,539	49,245,957	RGD:6480464	CTD
G	DERA	deoxyribose-phosphate aldolase (putative)		affects response to substance	EXP	12	16,064,186	16,190,315	RGD:6480464	CTD
G	DFFB	DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase)		affects response to substance	EXP	1	3,773,845	3,801,993	RGD:6480464	CTD
G	DKK1	dickkopf WNT signaling pathway inhibitor 1		affects response to substance	EXP	10	54,074,041	54,077,417	RGD:6480464	CTD
G	DKK3	dickkopf WNT signaling pathway inhibitor 3		affects response to substance	EXP	11	11,984,543	12,030,917	RGD:6480464	CTD
G	DONSON	downstream neighbor of SON		affects response to substance	EXP	21	34,949,857	34,961,014	RGD:6480464	CTD
G	E2F1	E2F transcription factor 1		increases response to substance	EXP	20	32,263,292	32,274,210	RGD:6480464	CTD
G	EDNRB	endothelin receptor type B		increases expression	ISO	13 13	78,469,616 78,513,393	78,549,664 78,549,674	RGD:6480464	CTD
G	EFCAB7	EF-hand calcium binding domain 7		affects response to substance	EXP	1	63,989,013	64,038,364	RGD:6480464	CTD
G	EMP2	epithelial membrane protein 2		affects response to substance	EXP	16	10,622,279	10,674,539	RGD:6480464	CTD
G	EPCAM	epithelial cell adhesion molecule		affects response to substance	EXP	2	47,596,287	47,614,167	RGD:6480464	CTD
G	EPRS	glutamyl-prolyl-tRNA synthetase		increases expression	ISO	1	220,141,942	220,220,000	RGD:6480464	CTD
G	ERBB2	v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)		affects response to substance	EXP	17	37,844,393	37,884,915	RGD:6480464	CTD
G	EREG	epiregulin		affects response to substance	EXP	4	75,230,860	75,254,477	RGD:6480464	CTD
G	ESM1	endothelial cell-specific molecule 1		decreases expression	ISO	5	54,273,695	54,281,414	RGD:6480464	CTD
G	ETFB	electron-transfer-flavoprotein, beta polypeptide		affects response to substance	EXP	19	51,848,409	51,869,672	RGD:6480464	CTD
G	EXOSC9	exosome component 9		affects response to substance	EXP	4	122,722,472	122,738,176	RGD:6480464	CTD
G	F3	coagulation factor III (thromboplastin, tissue factor)		increases expression	ISO	1	94,994,732	95,007,413	RGD:6480464	CTD
G	FAM3C	family with sequence similarity 3, member C		affects response to substance	EXP	7	120,988,905	121,036,422	RGD:6480464	CTD
G	FAM69A	family with sequence similarity 69, member A		affects response to substance	EXP	1	93,298,286	93,427,079	RGD:6480464	CTD
G	FANCL	Fanconi anemia, complementation group L		affects response to substance	EXP	2	58,386,378	58,468,515	RGD:6480464	CTD
G	FASLG	Fas ligand (TNF superfamily, member 6)		increases expression	EXP	1	172,628,185	172,636,013	RGD:6480464	CTD
G	FCGR2B	Fc fragment of IgG, low affinity IIb, receptor (CD32)		increases expression	ISO	1	161,632,905	161,648,444	RGD:6480464	CTD
G	FEN1	flap structure-specific endonuclease 1		affects response to substance	EXP	11	61,560,109	61,564,716	RGD:6480464	CTD
G	FKBP1A	FK506 binding protein 1A, 12kDa		affects response to substance	EXP	20	1,349,621	1,373,816	RGD:6480464	CTD
G	FLI1	Friend leukemia virus integration 1		affects response to substance	EXP	11	128,556,430	128,683,162	RGD:6480464	CTD
G	FN1	fibronectin 1		affects response to substance	EXP	2	216,225,177	216,300,791	RGD:6480464	CTD
G	FOSL1	FOS-like antigen 1		affects response to substance	EXP	11	65,659,692	65,667,997	RGD:6480464	CTD
G	G0S2	G0/G1switch 2		affects response to substance	EXP	1	209,848,670	209,849,735	RGD:6480464	CTD
G	GADD45A	growth arrest and DNA-damage-inducible, alpha		increases expression	ISO	1	68,150,860	68,154,021	RGD:6480464	CTD
G	GADD45B	growth arrest and DNA-damage-inducible, beta		increases expression	ISO	19	2,476,123	2,478,257	RGD:6480464	CTD
G	GADD45G	growth arrest and DNA-damage-inducible, gamma		increases expression	ISO	9	92,219,927	92,221,470	RGD:6480464	CTD
G	GAS7	growth arrest-specific 7		decreases expression	ISO	17	9,813,926	10,101,868	RGD:6480464	CTD
G	GGCT	gamma-glutamylcyclotransferase		affects response to substance	EXP	7	30,536,237	30,544,457	RGD:6480464	CTD
G	GGCX	gamma-glutamyl carboxylase		affects response to substance	EXP	2	85,771,978	85,788,657	RGD:6480464	CTD
G	GMNN	geminin, DNA replication inhibitor		affects response to substance	EXP	6	24,775,159	24,786,327	RGD:6480464	CTD
G	GNPTAB	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits		affects response to substance	EXP	12	102,139,275	102,224,645	RGD:6480464	CTD
G	GPR176	G protein-coupled receptor 176		affects response to substance	EXP	15	40,092,931	40,213,093	RGD:6480464	CTD
G	GPSM2	G-protein signaling modulator 2		affects response to substance	EXP	1	109,419,603	109,473,044	RGD:6480464	CTD
G	GSTP1	glutathione S-transferase pi 1		decreases response to substance	ISO	11	67,351,066	67,354,124	RGD:6480464	CTD
G	GTF2I	general transcription factor IIi		affects response to substance	EXP	7	74,072,030	74,175,022	RGD:6480464	CTD
G	GTF3A	general transcription factor IIIA		affects response to substance	EXP	13	27,998,681	28,009,846	RGD:6480464	CTD
G	GTSE1	G-2 and S-phase expressed 1		affects response to substance	EXP	22	46,692,638	46,726,707	RGD:6480464	CTD
G	GUSB	glucuronidase, beta		affects response to substance	EXP	7	65,425,671	65,447,301	RGD:6480464	CTD
G	HADH	hydroxyacyl-CoA dehydrogenase		affects response to substance	EXP	4	108,910,870	108,956,331	RGD:6480464	CTD
G	HCLS1	hematopoietic cell-specific Lyn substrate 1		affects response to substance	EXP	3	121,350,246	121,379,791	RGD:6480464	CTD
G	HIST1H1C	histone cluster 1, H1c		affects response to substance	EXP	6	26,055,968	26,056,699	RGD:6480464	CTD
G	HMGB1	high mobility group box 1		affects response to substance	EXP	13	31,032,877	31,040,081	RGD:6480464	CTD
G	HMGB2	high mobility group box 2		affects response to substance	EXP	4	174,252,527	174,255,595	RGD:6480464	CTD
G	HMGN3	high mobility group nucleosomal binding domain 3		affects response to substance	EXP	6	79,910,962	79,944,455	RGD:6480464	CTD
G	HMMR	hyaluronan-mediated motility receptor (RHAMM)		affects response to substance	EXP	5	162,887,517	162,918,951	RGD:6480464	CTD
G	HMOX1	heme oxygenase (decycling) 1		increases expression	ISO	22	35,777,060	35,790,207	RGD:6480464	CTD
G	HOMER1	homer homolog 1 (Drosophila)		affects response to substance	EXP	5	78,669,786	78,809,700	RGD:6480464	CTD
G	ICAM1	intercellular adhesion molecule 1		increases expression	ISO	19	10,381,517	10,397,291	RGD:6480464	CTD
G	ICAM1	intercellular adhesion molecule 1		decreases expression	EXP	19	10,381,517	10,397,291	RGD:6480464	CTD
G	ID2	inhibitor of DNA binding 2, dominant negative helix-loop-helix protein		affects response to substance	EXP	2	8,822,113	8,824,583	RGD:6480464	CTD
G	IDH2	isocitrate dehydrogenase 2 (NADP+), mitochondrial		affects response to substance	EXP	15	90,627,210	90,645,708	RGD:6480464	CTD
G	IGF2BP3	insulin-like growth factor 2 mRNA binding protein 3		affects response to substance	EXP	7	23,349,828	23,509,995	RGD:6480464	CTD
G	IKBKB	inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta		increases phosphorylation	EXP	8	42,128,820	42,190,171	RGD:6480464	CTD
G	IKBKB	inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta		multiple interactions	EXP	8	42,128,820	42,190,171	RGD:6480464	CTD
G	IL13RA2	interleukin 13 receptor, alpha 2		affects response to substance	EXP	X	114,238,538	114,252,207	RGD:6480464	CTD
G	IL1B	interleukin 1, beta		affects response to substance	EXP	2	113,587,337	113,594,356	RGD:6480464	CTD
G	IL1B	interleukin 1, beta		increases expression	ISO	2	113,587,337	113,594,356	RGD:6480464	CTD
G	IL6	interleukin 6 (interferon, beta 2)		increases stability	EXP	7	22,766,766	22,771,621	RGD:6480464	CTD
G	IL6	interleukin 6 (interferon, beta 2)		decreases chemical synthesis	EXP	7	22,766,766	22,771,621	RGD:6480464	CTD
G	IL8	interleukin 8		affects response to substance	EXP	4	74,606,223	74,609,433	RGD:6480464	CTD
G	IL8	interleukin 8		increases stability	EXP	4	74,606,223	74,609,433	RGD:6480464	CTD
G	IL8	interleukin 8		multiple interactions	EXP	4	74,606,223	74,609,433	RGD:6480464	CTD
G	INHA	inhibin, alpha		decreases expression	ISO	2	220,436,954	220,440,435	RGD:6480464	CTD
G	INHBA	inhibin, beta A		affects response to substance	EXP	7	41,728,601	41,742,706	RGD:6480464	CTD
G	ITGAL	integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)		decreases expression	EXP	16	30,483,983	30,534,506	RGD:6480464	CTD
G	ITGB1BP1	integrin beta 1 binding protein 1		affects response to substance	EXP	2	9,545,813	9,563,643	RGD:6480464	CTD
G	JUN	jun proto-oncogene		increases phosphorylation	EXP	1	59,246,463	59,249,785	RGD:6480464	CTD
G	JUN	jun proto-oncogene		multiple interactions	EXP	1	59,246,463	59,249,785	RGD:6480464	CTD
G	KANK1	KN motif and ankyrin repeat domains 1		affects response to substance	EXP	9	470,294	746,106	RGD:6480464	CTD
G	KAZN	kazrin, periplakin interacting protein		affects response to substance	EXP	1	14,925,213	15,444,544	RGD:6480464	CTD
G	KIAA1598	KIAA1598		affects response to substance	EXP	10	118,642,888	118,886,097	RGD:6480464	CTD
G	KIF11	kinesin family member 11		affects response to substance	EXP	10	94,352,825	94,415,152	RGD:6480464	CTD
G	KIF15	kinesin family member 15		affects response to substance	EXP	3	44,803,209	44,894,748	RGD:6480464	CTD
G	KIF1B	kinesin family member 1B		affects response to substance	EXP	1	10,270,764	10,441,661	RGD:6480464	CTD
G	KIF20A	kinesin family member 20A		affects response to substance	EXP	5	137,514,417	137,523,404	RGD:6480464	CTD
G	KIF23	kinesin family member 23		affects response to substance	EXP	15	69,706,627	69,740,764	RGD:6480464	CTD
G	KIF4A	kinesin family member 4A		affects response to substance	EXP	X	69,509,879	69,640,774	RGD:6480464	CTD
G	KPNA2	karyopherin alpha 2 (RAG cohort 1, importin alpha 1)		affects response to substance	EXP	17	66,031,848	66,042,970	RGD:6480464	CTD
G	LMNB1	lamin B1		affects response to substance	EXP	5	126,112,315	126,172,712	RGD:6480464	CTD
G	LPAR1	lysophosphatidic acid receptor 1		affects response to substance	EXP	9	113,636,054	113,800,365	RGD:6480464	CTD
G	LRRC1	leucine rich repeat containing 1		affects response to substance	EXP	6	53,659,778	53,788,919	RGD:6480464	CTD
G	LSM7	LSM7 homolog, U6 small nuclear RNA associated (S. cerevisiae)		affects response to substance	EXP	19	2,321,520	2,328,614	RGD:6480464	CTD
G	LTBP2	latent transforming growth factor beta binding protein 2		affects response to substance	EXP	14	74,964,886	75,079,034	RGD:6480464	CTD
G	MAD2L1	MAD2 mitotic arrest deficient-like 1 (yeast)		affects response to substance	EXP	4	120,980,577	120,988,013	RGD:6480464	CTD
G	MAPK8	mitogen-activated protein kinase 8		increases phosphorylation	EXP	10	49,609,687	49,643,183	RGD:6480464	CTD
G	MAPK8	mitogen-activated protein kinase 8		multiple interactions	EXP	10	49,609,687	49,643,183	RGD:6480464	CTD
G	MAPK9	mitogen-activated protein kinase 9		multiple interactions	EXP	5	179,660,594	179,719,071	RGD:6480464	CTD
G	MAPK9	mitogen-activated protein kinase 9		increases phosphorylation	EXP	5	179,660,594	179,719,071	RGD:6480464	CTD
G	MAPKAPK5	mitogen-activated protein kinase-activated protein kinase 5		affects response to substance	EXP	12	112,280,279	112,331,228	RGD:6480464	CTD
G	MELK	maternal embryonic leucine zipper kinase		affects response to substance	EXP	9	36,572,859	36,677,680	RGD:6480464	CTD
G	MME	membrane metallo-endopeptidase		affects response to substance	EXP	3	154,797,436	154,901,518	RGD:6480464	CTD
G	MMP1	matrix metallopeptidase 1 (interstitial collagenase)		affects response to substance	EXP	11	102,660,641	102,668,966	RGD:6480464	CTD
G	MOK	MOK protein kinase		affects response to substance	EXP	14	102,695,178	102,771,531	RGD:6480464	CTD
G	MRP63	mitochondrial ribosomal protein 63		affects response to substance	EXP	13	21,750,372	21,753,223	RGD:6480464	CTD
G	MST4	serine/threonine protein kinase MST4		affects response to substance	EXP	X	131,157,245	131,209,971	RGD:6480464	CTD
G	MYC	v-myc myelocytomatosis viral oncogene homolog (avian)		affects response to substance	EXP	8	128,748,315	128,753,680	RGD:6480464	CTD
G	MYC	v-myc myelocytomatosis viral oncogene homolog (avian)		increases expression	ISO	8	128,748,315	128,753,680	RGD:6480464	CTD
G	MYCBP	c-myc binding protein		affects response to substance	EXP	1	39,328,162	39,339,050	RGD:6480464	CTD
G	NBN	nibrin		increases expression	ISO	8	90,945,564	90,996,899	RGD:6480464	CTD
G	NCAPG	non-SMC condensin I complex, subunit G		affects response to substance	EXP	4	17,812,436	17,846,488	RGD:6480464	CTD
G	NCAPH	non-SMC condensin I complex, subunit H		affects response to substance	EXP	2	97,001,484	97,041,274	RGD:6480464	CTD
G	NDC80	NDC80 kinetochore complex component		affects response to substance	EXP	18	2,571,510	2,616,634	RGD:6480464	CTD
G	NDUFA1	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa		affects response to substance	EXP	X	119,005,734	119,010,629	RGD:6480464	CTD
G	NDUFA13	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13		affects response to substance	EXP	19	19,627,019	19,639,013	RGD:6480464	CTD
G	NDUFA3	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3, 9kDa		affects response to substance	EXP	19	54,606,160	54,610,281	RGD:6480464	CTD
G	NDUFA7	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7, 14.5kDa		affects response to substance	EXP	19	8,376,184	8,386,280	RGD:6480464	CTD
G	NDUFB2	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa		affects response to substance	EXP	7	140,396,481	140,406,446	RGD:6480464	CTD
G	NDUFC1	NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1, 6kDa		affects response to substance	EXP	4	140,211,071	140,223,705	RGD:6480464	CTD
G	NDUFC2	NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa		affects response to substance	EXP	11	77,779,393	77,791,265	RGD:6480464	CTD
G	NDUFS6	NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kDa (NADH-coenzyme Q reductase)		affects response to substance	EXP	5	1,801,496	1,816,165	RGD:6480464	CTD
G	NDUFV2	NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa		affects response to substance	EXP	18	9,102,628	9,134,343	RGD:6480464	CTD
G	NFATC4	nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4		decreases localization	EXP	14	24,836,145	24,848,810	RGD:6480464	CTD
G	NFKBIA	nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha		increases phosphorylation	EXP	14	35,870,716	35,873,960	RGD:6480464	CTD
G	NFKBIA	nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha		multiple interactions	EXP	14	35,870,716	35,873,960	RGD:6480464	CTD
G	NGF	nerve growth factor (beta polypeptide)		decreases response to substance	ISO	1	115,828,537	115,880,857	RGD:6480464	CTD
G	NPY	neuropeptide Y		decreases expression	ISO	7	24,323,807	24,331,484	RGD:6480464	CTD
G	NQO1	NAD(P)H dehydrogenase, quinone 1		multiple interactions	ISO	16	69,743,304	69,760,533	RGD:6480464	CTD
G	NR1I2	nuclear receptor subfamily 1, group I, member 2		multiple interactions	EXP	3	119,499,331	119,537,332	RGD:6480464	CTD
G	NR1I2	nuclear receptor subfamily 1, group I, member 2		increases activity	EXP	3	119,499,331	119,537,332	RGD:6480464	CTD
G	NSMAF	neutral sphingomyelinase (N-SMase) activation associated factor		affects response to substance	EXP	8	59,496,063	59,572,404	RGD:6480464	CTD
G	NUDT15	nudix (nucleoside diphosphate linked moiety X)-type motif 15		affects response to substance	EXP	13	48,611,703	48,621,282	RGD:6480464	CTD
G	NUDT4	nudix (nucleoside diphosphate linked moiety X)-type motif 4		affects response to substance	EXP	12	93,771,701	93,797,024	RGD:6480464	CTD
G	NUSAP1	nucleolar and spindle associated protein 1		affects response to substance	EXP	15	41,624,892	41,673,248	RGD:6480464	CTD
G	OAZ1	ornithine decarboxylase antizyme 1		affects response to substance	EXP	19	2,269,520	2,273,487	RGD:6480464	CTD
G	ODC1	ornithine decarboxylase 1		multiple interactions	ISO	2	10,580,508	10,588,453	RGD:6480464	CTD
G	OIP5	Opa interacting protein 5		affects response to substance	EXP	15	41,601,466	41,624,819	RGD:6480464	CTD
G	OR10B1P	olfactory receptor, family 10, subfamily B, member 1 pseudogene		affects response to substance	EXP	19	15,251,943	15,252,849	RGD:6480464	CTD
G	OR1I1	olfactory receptor, family 1, subfamily I, member 1		affects response to substance	EXP	19	15,197,877	15,198,944	RGD:6480464	CTD
G	ORC6	origin recognition complex, subunit 6		affects response to substance	EXP	16	46,723,558	46,732,306	RGD:6480464	CTD
G	OSBPL10	oxysterol binding protein-like 10		affects response to substance	EXP	3	31,702,317	32,023,342	RGD:6480464	CTD
G	PDHB	pyruvate dehydrogenase (lipoamide) beta		affects response to substance	EXP	3	58,413,357	58,419,579	RGD:6480464	CTD
G	PELO	pelota homolog (Drosophila)		affects response to substance	EXP	5	52,083,774	52,098,451	RGD:6480464	CTD
G	PGRMC1	progesterone receptor membrane component 1		affects response to substance	EXP	X	118,370,211	118,378,429	RGD:6480464	CTD
G	PIR	pirin (iron-binding nuclear protein)		affects response to substance	EXP	X	15,402,921	15,511,711	RGD:6480464	CTD
G	PLAGL1	pleiomorphic adenoma gene-like 1		increases expression	ISO	6	144,261,437	144,385,735	RGD:6480464	CTD
G	PLAT	plasminogen activator, tissue		increases expression	ISO	8	42,032,236	42,065,194	RGD:6480464	CTD
G	PLAU	plasminogen activator, urokinase		affects response to substance	EXP	10	75,670,862	75,677,259	RGD:6480464	CTD
G	PLAUR	plasminogen activator, urokinase receptor		increases expression	ISO	19	44,150,247	44,174,498	RGD:6480464	CTD
G	PPP1R15A	protein phosphatase 1, regulatory subunit 15A		increases expression	ISO	19	49,375,649	49,379,319	RGD:6480464	CTD
G	PRC1	protein regulator of cytokinesis 1		affects response to substance	EXP	15	91,509,268	91,537,881	RGD:6480464	CTD
G	PSMB1	proteasome (prosome, macropain) subunit, beta type, 1		affects response to substance	EXP	6	170,844,204	170,862,417	RGD:6480464	CTD
G	PSME4	proteasome (prosome, macropain) activator subunit 4		affects response to substance	EXP	2	54,091,204	54,197,977	RGD:6480464	CTD
G	PTGES3	prostaglandin E synthase 3 (cytosolic)		affects response to substance	EXP	12	57,057,125	57,082,078	RGD:6480464	CTD
G	PTTG1	pituitary tumor-transforming 1		affects response to substance	EXP	5	159,848,865	159,855,746	RGD:6480464	CTD
G	PTX3	pentraxin 3, long		affects response to substance	EXP	3	157,154,580	157,161,417	RGD:6480464	CTD
G	QRICH1	glutamine-rich 1		increases phosphorylation	EXP	3	49,067,142	49,131,504	RGD:6480464	CTD
G	RAB11FIP1	RAB11 family interacting protein 1 (class I)		affects response to substance	EXP	8	37,716,465	37,757,015	RGD:6480464	CTD
G	RACGAP1	Rac GTPase activating protein 1		affects response to substance	EXP	12	50,382,945	50,419,307	RGD:6480464	CTD
G	RANBP1	RAN binding protein 1		affects response to substance	EXP	22	20,105,024	20,114,704	RGD:6480464	CTD
G	RASSF1	Ras association (RalGDS/AF-6) domain family member 1		increases expression	ISO	3	50,367,217	50,378,367	RGD:6480464	CTD
G	REV3L	REV3-like, polymerase (DNA directed), zeta, catalytic subunit		affects response to substance	EXP	6	111,620,234	111,804,414	RGD:6480464	CTD
G	RFC5	replication factor C (activator 1) 5, 36.5kDa		affects response to substance	EXP	12	118,454,506	118,470,044	RGD:6480464	CTD
G	RPA3	replication protein A3, 14kDa		affects response to substance	EXP	7	7,676,575	7,758,238	RGD:6480464	CTD
G	RRM2	ribonucleotide reductase M2		affects response to substance	EXP	2	10,262,695	10,271,546	RGD:6480464	CTD
G	S100A8	S100 calcium binding protein A8		increases expression	ISO	1	153,362,508	153,363,664	RGD:6480464	CTD
G	S100A9	S100 calcium binding protein A9		increases expression	ISO	1	153,330,330	153,333,503	RGD:6480464	CTD
G	SELE	selectin E		increases expression	ISO	1	169,691,781	169,703,220	RGD:6480464	CTD
G	SERPINB2	serpin peptidase inhibitor, clade B (ovalbumin), member 2		affects response to substance	EXP	18	61,554,939	61,571,124	RGD:6480464	CTD
G	SERPINE1	serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1		increases expression	ISO	7	100,770,370	100,782,547	RGD:6480464	CTD
G	SERPINE1	serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1		affects response to substance	EXP	7	100,770,370	100,782,547	RGD:6480464	CTD
G	SFXN1	sideroflexin 1		affects response to substance	EXP	5	174,905,514	174,955,621	RGD:6480464	CTD
G	SKP2	S-phase kinase-associated protein 2, E3 ubiquitin protein ligase		affects response to substance	EXP	5	36,152,145	36,184,143	RGD:6480464	CTD
G	SLC22A3	solute carrier family 22 (extraneuronal monoamine transporter), member 3		affects response to substance	EXP	6	160,769,405	160,873,611	RGD:6480464	CTD
G	SNRNP25	small nuclear ribonucleoprotein 25kDa (U11/U12)		affects response to substance	EXP	16	103,829	107,669	RGD:6480464	CTD
G	SNX10	sorting nexin 10		affects response to substance	EXP	7	26,331,515	26,413,949	RGD:6480464	CTD
G	SOD1	superoxide dismutase 1, soluble		affects response to substance	EXP	21	33,031,935	33,041,244	RGD:6480464	CTD
G	SORT1	sortilin 1		affects response to substance	EXP	1	109,852,187	109,940,563	RGD:6480464	CTD
G	SPON1	spondin 1, extracellular matrix protein		increases expression	ISO	11	13,984,184	14,289,679	RGD:6480464	CTD
G	SRD5A1	steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)		affects response to substance	EXP	5	6,633,500	6,669,675	RGD:6480464	CTD
G	SRGN	serglycin		affects response to substance	EXP	10	70,847,828	70,864,567	RGD:6480464	CTD
G	STC2	stanniocalcin 2		affects response to substance	EXP	5	172,741,726	172,756,506	RGD:6480464	CTD
G	STK17A	serine/threonine kinase 17a		increases expression	ISO	7	43,622,692	43,666,978	RGD:6480464	CTD
G	STRN	striatin, calmodulin binding protein		affects response to substance	EXP	2	37,064,841	37,193,615	RGD:6480464	CTD
G	SUCLA2	succinate-CoA ligase, ADP-forming, beta subunit		affects response to substance	EXP	13	48,516,791	48,575,462	RGD:6480464	CTD
G	SUCLG1	succinate-CoA ligase, alpha subunit		affects response to substance	EXP	2	84,650,647	84,686,586	RGD:6480464	CTD
G	SULT1A1	sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1		affects response to substance	EXP	16	28,616,908	28,634,907	RGD:6480464	CTD
G	SYDE1	synapse defective 1, Rho GTPase, homolog 1 (C. elegans)		affects response to substance	EXP	19	15,218,214	15,225,789	RGD:6480464	CTD
G	TBC1D4	TBC1 domain family, member 4		affects response to substance	EXP	13	75,858,809	76,056,250	RGD:6480464	CTD
G	TDG	thymine-DNA glycosylase		affects response to substance	EXP	12	104,359,593	104,382,656	RGD:6480464	CTD
G	TFPI2	tissue factor pathway inhibitor 2		affects response to substance	EXP	7	93,514,709	93,520,303	RGD:6480464	CTD
G	TFPI2	tissue factor pathway inhibitor 2		increases expression	ISO	7	93,514,709	93,520,303	RGD:6480464	CTD
G	THBD	thrombomodulin		increases expression	ISO	20	23,026,270	23,030,301	RGD:6480464	CTD
G	THBS1	thrombospondin 1		increases expression	ISO	15	39,873,280	39,889,668	RGD:6480464	CTD
G	TIMP1	TIMP metallopeptidase inhibitor 1		increases expression	ISO	X	47,441,690	47,446,190	RGD:6480464	CTD
G	TMEM134	transmembrane protein 134		affects response to substance	EXP	11	67,231,819	67,236,731	RGD:6480464	CTD
G	TMEM14A	transmembrane protein 14A		affects response to substance	EXP	6	52,535,884	52,551,386	RGD:6480464	CTD
G	TMEM156	transmembrane protein 156		affects response to substance	EXP	4	38,968,422	39,034,041	RGD:6480464	CTD
G	TMEM246	transmembrane protein 246		affects response to substance	EXP	9	104,237,608	104,249,475	RGD:6480464	CTD
G	TMEM97	transmembrane protein 97		affects response to substance	EXP	17	26,646,121	26,655,711	RGD:6480464	CTD
G	TMPO	thymopoietin		affects response to substance	EXP	12	98,909,351	98,944,157	RGD:6480464	CTD
G	TOP2A	topoisomerase (DNA) II alpha 170kDa		affects response to substance	EXP	17	38,544,773	38,574,202	RGD:6480464	CTD
G	TP53	tumor protein p53		multiple interactions	EXP	17	7,571,720	7,590,868	RGD:6480464	CTD
G	TPD52L1	tumor protein D52-like 1		increases expression	ISO	6	125,474,879	125,584,644	RGD:6480464	CTD
G	TPD52L1	tumor protein D52-like 1		affects response to substance	EXP	6	125,474,879	125,584,644	RGD:6480464	CTD
G	TRIM2	tripartite motif containing 2		affects response to substance	EXP	4	154,074,270	154,260,474	RGD:6480464	CTD
G	TRMT5	tRNA methyltransferase 5 homolog (S. cerevisiae)		affects response to substance	EXP	14	61,438,159	61,447,782	RGD:6480464	CTD
G	TSPAN13	tetraspanin 13		affects response to substance	EXP	7	16,793,351	16,824,161	RGD:6480464	CTD
G	TTF2	transcription termination factor, RNA polymerase II		affects response to substance	EXP	1	117,602,949	117,645,492	RGD:6480464	CTD
G	TTK	TTK protein kinase		affects response to substance	EXP	6	80,714,322	80,752,244	RGD:6480464	CTD
G	TUBA1B	tubulin, alpha 1b		decreases expression	ISO	12	49,521,565	49,525,304	RGD:6480464	CTD
G	TUBA4A	tubulin, alpha 4a		decreases expression	ISO	2	220,115,001	220,118,638	RGD:6480464	CTD
G	TUBB	tubulin, beta class I		decreases expression	ISO	6	30,688,157	30,693,199	RGD:6480464	CTD
G	TUBB4B	tubulin, beta 4B class IVb		decreases expression	ISO	9	140,135,711	140,138,159	RGD:6480464	CTD
G	TUBG1	tubulin, gamma 1		decreases expression	ISO	17	40,761,358	40,767,256	RGD:6480464	CTD
G	VCAM1	vascular cell adhesion molecule 1		increases expression	ISO	1	101,185,196	101,204,601	RGD:6480464	CTD
G	VEGFA	vascular endothelial growth factor A		decreases expression	ISO	6	43,737,946	43,754,224	RGD:6480464	CTD
G	VEGFC	vascular endothelial growth factor C		affects response to substance	EXP	4	177,604,691	177,713,895	RGD:6480464	CTD
G	VWF	von Willebrand factor		increases expression	ISO	12	6,058,040	6,233,836	RGD:6480464	CTD
G	WDR61	WD repeat domain 61		affects response to substance	EXP	15	78,575,577	78,591,940	RGD:6480464	CTD
G	WSB2	WD repeat and SOCS box containing 2		affects response to substance	EXP	12	118,470,492	118,498,951	RGD:6480464	CTD
G	YWHAQ	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide		affects response to substance	EXP	2	9,724,106	9,771,106	RGD:6480464	CTD
G	ZDHHC11	zinc finger, DHHC-type containing 11		affects response to substance	EXP	5	795,720	851,101	RGD:6480464	CTD
G	ZFP36L2	ZFP36 ring finger protein-like 2		affects response to substance	EXP	2	43,449,541	43,453,745	RGD:6480464	CTD
G	ZWINT	ZW10 interactor, kinetochore protein		affects response to substance	EXP	10	58,117,199	58,121,034	RGD:6480464	CTD
vincristine
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1		multiple interactions	EXP	9	107,543,283	107,690,527	RGD:6480464	CTD
G	ABCA12	ATP-binding cassette, sub-family A (ABC1), member 12		multiple interactions	EXP	2	215,796,266	216,003,151	RGD:6480464	CTD
G	ABCA4	ATP-binding cassette, sub-family A (ABC1), member 4		multiple interactions	EXP	1	94,458,393	94,586,705	RGD:6480464	CTD
G	ABCA5	ATP-binding cassette, sub-family A (ABC1), member 5		multiple interactions	EXP	17	67,240,576	67,323,323	RGD:6480464	CTD
G	ABCA8	ATP-binding cassette, sub-family A (ABC1), member 8		multiple interactions	EXP	17	66,863,430	66,951,533	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		affects uptake	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		affects response to substance	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		decreases response to substance	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		decreases uptake	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		multiple interactions	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		multiple interactions	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		multiple interactions	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		multiple interactions	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		increases expression	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		multiple interactions	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		increases expression	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		increases transport	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		multiple interactions	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		increases expression	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		multiple interactions	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		increases expression	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11		increases response to substance	EXP	2	169,779,449	169,887,833	RGD:6480464	CTD
G	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4		multiple interactions	EXP	7	87,031,361	87,105,019	RGD:6480464	CTD
G	ABCB6	ATP-binding cassette, sub-family B (MDR/TAP), member 6		multiple interactions	EXP	2	220,074,488	220,083,712	RGD:6480464	CTD
G	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1		increases response to substance	EXP	16	16,043,434	16,236,931	RGD:6480464	CTD
G	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1		multiple interactions	EXP	16	16,043,434	16,236,931	RGD:6480464	CTD
G	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1		affects export	EXP	16	16,043,434	16,236,931	RGD:6480464	CTD
G	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1		affects response to substance	EXP	16	16,043,434	16,236,931	RGD:6480464	CTD
G	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1		affects transport	EXP	16	16,043,434	16,236,931	RGD:6480464	CTD
G	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1		affects transport	EXP	16	16,043,434	16,236,931	RGD:6480464	CTD
G	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1		decreases response to substance	EXP	16	16,043,434	16,236,931	RGD:6480464	CTD
G	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1		multiple interactions	EXP	16	16,043,434	16,236,931	RGD:6480464	CTD
G	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1		multiple interactions	EXP	16	16,043,434	16,236,931	RGD:6480464	CTD
G	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1		multiple interactions	EXP	16	16,043,434	16,236,931	RGD:6480464	CTD
G	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1		multiple interactions	EXP	16	16,043,434	16,236,931	RGD:6480464	CTD
G	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1		multiple interactions	ISO	16	16,043,434	16,236,931	RGD:6480464	CTD
G	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1		increases expression	ISO	16	16,043,434	16,236,931	RGD:6480464	CTD
G	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1		decreases response to substance	EXP	16	16,043,434	16,236,931	RGD:6480464	CTD
G	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1		decreases response to substance	EXP	16	16,043,434	16,236,931	RGD:6480464	CTD
G	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1		decreases response to substance	EXP	16	16,043,434	16,236,931	RGD:6480464	CTD
G	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1		decreases response to substance	EXP	16	16,043,434	16,236,931	RGD:6480464	CTD
G	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1		decreases response to substance	EXP	16	16,043,434	16,236,931	RGD:6480464	CTD
G	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1		affects transport	EXP	16	16,043,434	16,236,931	RGD:6480464	CTD
G	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1		decreases response to substance	EXP	16	16,043,434	16,236,931	RGD:6480464	CTD
G	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1		multiple interactions	EXP	16	16,043,434	16,236,931	RGD:6480464	CTD
G	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1		multiple interactions	EXP	16	16,043,434	16,236,931	RGD:6480464	CTD
G	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1		decreases response to substance	ISO	16	16,043,434	16,236,931	RGD:6480464	CTD
G	ABCC10	ATP-binding cassette, sub-family C (CFTR/MRP), member 10		multiple interactions	EXP	6	43,395,292	43,418,163	RGD:6480464	CTD
G	ABCC10	ATP-binding cassette, sub-family C (CFTR/MRP), member 10		decreases response to substance	EXP	6	43,395,292	43,418,163	RGD:6480464	CTD
G	ABCC2	ATP-binding cassette, sub-family C (CFTR/MRP), member 2		multiple interactions	EXP	10	101,542,463	101,611,662	RGD:6480464	CTD
G	ABCC2	ATP-binding cassette, sub-family C (CFTR/MRP), member 2		affects export	EXP	10	101,542,463	101,611,662	RGD:6480464	CTD
G	ABCC2	ATP-binding cassette, sub-family C (CFTR/MRP), member 2		decreases response to substance	EXP	10	101,542,463	101,611,662	RGD:6480464	CTD
G	ABCC2	ATP-binding cassette, sub-family C (CFTR/MRP), member 2		multiple interactions	EXP	10	101,542,463	101,611,662	RGD:6480464	CTD
G	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3		multiple interactions	EXP	17	48,712,218	48,769,063	RGD:6480464	CTD
G	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4		increases response to substance	EXP	13	95,672,083	95,953,687	RGD:6480464	CTD
G	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4		multiple interactions	EXP	13	95,672,083	95,953,687	RGD:6480464	CTD
G	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5		increases response to substance	EXP	3	183,637,722	183,735,727	RGD:6480464	CTD
G	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5		multiple interactions	EXP	3	183,637,722	183,735,727	RGD:6480464	CTD
G	ABCC6	ATP-binding cassette, sub-family C (CFTR/MRP), member 6		multiple interactions	EXP	16	16,243,422	16,317,328	RGD:6480464	CTD
G	ABCD3	ATP-binding cassette, sub-family D (ALD), member 3		multiple interactions	EXP	1	94,883,933	94,984,219	RGD:6480464	CTD
G	ABCG1	ATP-binding cassette, sub-family G (WHITE), member 1		multiple interactions	EXP	21	43,619,799	43,717,354	RGD:6480464	CTD
G	ABCG2	ATP-binding cassette, sub-family G (WHITE), member 2		multiple interactions	EXP	4	89,011,416	89,152,474	RGD:6480464	CTD
G	ABCG2	ATP-binding cassette, sub-family G (WHITE), member 2		multiple interactions	EXP	4	89,011,416	89,152,474	RGD:6480464	CTD
G	ABCG4	ATP-binding cassette, sub-family G (WHITE), member 4		multiple interactions	EXP	11	119,019,750	119,033,375	RGD:6480464	CTD
G	ACHE	acetylcholinesterase		decreases expression	ISO	7	100,487,615	100,493,541	RGD:6480464	CTD
G	ACHE	acetylcholinesterase		multiple interactions	ISO	7	100,487,615	100,493,541	RGD:6480464	CTD
G	ACTL8	actin-like 8		increases response to substance	EXP	1	18,081,808	18,153,558	RGD:6480464	CTD
G	ADRB2	adrenoceptor beta 2, surface		increases response to substance	EXP	5	148,206,156	148,208,197	RGD:6480464	CTD
G	ADRB2	adrenoceptor beta 2, surface		increases response to substance	EXP	5	148,206,156	148,208,197	RGD:6480464	CTD
G	AICDA	activation-induced cytidine deaminase		increases response to substance	EXP	12	8,754,762	8,765,442	RGD:6480464	CTD
G	AK1	adenylate kinase 1		decreases expression	ISO	9	130,628,759	130,640,022	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		multiple interactions	EXP	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		multiple interactions	ISO	14	105,235,686	105,262,080	RGD:6480464	CTD
G	ALDH1A1	aldehyde dehydrogenase 1 family, member A1		increases response to substance	EXP	9	75,515,578	75,568,233	RGD:6480464	CTD
G	APLN	apelin		decreases expression	ISO	X	128,779,236	128,788,933	RGD:6480464	CTD
G	ARSA	arylsulfatase A		increases response to substance	EXP	22	51,061,182	51,066,601	RGD:6480464	CTD
G	ASPM	asp (abnormal spindle) homolog, microcephaly associated (Drosophila)		increases expression	EXP	1	197,053,257	197,115,824	RGD:6480464	CTD
G	ATP7A	ATPase, Cu++ transporting, alpha polypeptide		decreases response to substance	EXP	X	77,166,194	77,305,892	RGD:6480464	CTD
G	ATP7B	ATPase, Cu++ transporting, beta polypeptide		increases response to substance	EXP	13	52,506,805	52,585,630	RGD:6480464	CTD
G	AURKA	aurora kinase A		increases response to substance	EXP	20	54,944,445	54,967,351	RGD:6480464	CTD
G	AURKA	aurora kinase A		increases expression	EXP	20	54,944,445	54,967,351	RGD:6480464	CTD
G	AVP	arginine vasopressin		increases expression	EXP	20	3,063,202	3,065,370	RGD:6480464	CTD
G	BAK1	BCL2-antagonist/killer 1		affects response to substance	EXP	6	33,540,323	33,548,070	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		decreases expression	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		affects response to substance	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		increases phosphorylation	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		decreases response to substance	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2L1	BCL2-like 1		affects response to substance	EXP	20	30,252,261	30,310,656	RGD:6480464	CTD
G	BDKRB1	bradykinin receptor B1		multiple interactions	ISO	14	96,722,547	96,731,100	RGD:6480464	CTD
G	BDKRB2	bradykinin receptor B2		multiple interactions	ISO	14	96,671,135	96,710,666	RGD:6480464	CTD
G	BRCA1	breast cancer 1, early onset		increases response to substance	EXP	17	41,196,312	41,277,500	RGD:6480464	CTD
G	BRCA2	breast cancer 2, early onset		increases response to substance	EXP	13	32,889,617	32,973,809	RGD:6480464	CTD
G	C17orf96	chromosome 17 open reading frame 96		increases response to substance	EXP	17	36,827,956	36,831,187	RGD:6480464	CTD
G	CADPS	Ca++-dependent secretion activator		increases response to substance	EXP	3	62,384,021	62,861,064	RGD:6480464	CTD
G	CAMKK1	calcium/calmodulin-dependent protein kinase kinase 1, alpha		increases response to substance	EXP	17	3,763,609	3,796,337	RGD:6480464	CTD
G	CASC5	cancer susceptibility candidate 5		increases response to substance	EXP	15	40,886,447	40,954,881	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		increases cleavage	ISO	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP6	caspase 6, apoptosis-related cysteine peptidase		increases expression	EXP	4	110,609,785	110,624,629	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		increases expression	EXP	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CAT	catalase		affects response to substance	EXP	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CCL2	chemokine (C-C motif) ligand 2		increases expression	ISO	17	32,582,296	32,584,222	RGD:6480464	CTD
G	CCNA2	cyclin A2		increases response to substance	EXP	4	122,737,599	122,745,088	RGD:6480464	CTD
G	CCNB1	cyclin B1		affects response to substance	EXP	5	68,462,837	68,474,072	RGD:6480464	CTD
G	CD14	CD14 molecule		increases expression	ISO	5	140,011,313	140,013,286	RGD:6480464	CTD
G	CD36	CD36 molecule (thrombospondin receptor)		increases expression	ISO	7	80,231,504	80,308,593	RGD:6480464	CTD
G	CD44	CD44 molecule (Indian blood group)		increases response to substance	EXP	11	35,160,417	35,253,949	RGD:6480464	CTD
G	CDCA2	cell division cycle associated 2		increases response to substance	EXP	8	25,316,513	25,365,425	RGD:6480464	CTD
G	CDK5	cyclin-dependent kinase 5		increases response to substance	EXP	7	150,750,899	150,755,052	RGD:6480464	CTD
G	CDK7	cyclin-dependent kinase 7		increases response to substance	EXP	5	68,530,622	68,573,257	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		increases expression	ISO	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN2A	cyclin-dependent kinase inhibitor 2A		increases response to substance	EXP	9	21,967,751	21,994,490	RGD:6480464	CTD
G	CEBPB	CCAAT/enhancer binding protein (C/EBP), beta		increases expression	EXP	20	48,807,120	48,809,227	RGD:6480464	CTD
G	CEP250	centrosomal protein 250kDa		increases response to substance	EXP	20	34,043,223	34,099,803	RGD:6480464	CTD
G	CHST5	carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 5		increases response to substance	EXP	16	75,562,428	75,569,068	RGD:6480464	CTD
G	CIAPIN1	cytokine induced apoptosis inhibitor 1		decreases response to substance	EXP	16	57,462,086	57,481,369	RGD:6480464	CTD
G	COBL	cordon-bleu WH2 repeat protein		increases response to substance	EXP	7	51,083,909	51,384,515	RGD:6480464	CTD
G	COL9A3	collagen, type IX, alpha 3		increases response to substance	EXP	20	61,448,414	61,472,511	RGD:6480464	CTD
G	CP	ceruloplasmin (ferroxidase)		increases expression	ISO	3	148,880,197	148,939,832	RGD:6480464	CTD
G	CRIP1	cysteine-rich protein 1 (intestinal)		increases response to substance	EXP	14	105,953,257	105,955,126	RGD:6480464	CTD
G	CTNNB1	catenin (cadherin-associated protein), beta 1, 88kDa		decreases response to substance	EXP	3	41,240,942	41,281,939	RGD:6480464	CTD
G	CYP1A2	cytochrome P450, family 1, subfamily A, polypeptide 2		increases response to substance	EXP	15	75,041,184	75,048,941	RGD:6480464	CTD
G	CYP2C8	cytochrome P450, family 2, subfamily C, polypeptide 8		increases response to substance	EXP	10	96,796,529	96,829,254	RGD:6480464	CTD
G	CYP2C9	cytochrome P450, family 2, subfamily C, polypeptide 9		increases response to substance	EXP	10	96,698,415	96,749,148	RGD:6480464	CTD
G	CYP3A4	cytochrome P450, family 3, subfamily A, polypeptide 4		increases metabolic processing	EXP	7	99,354,583	99,381,811	RGD:6480464	CTD
G	CYP3A5	cytochrome P450, family 3, subfamily A, polypeptide 5		multiple interactions	EXP	7	99,245,813	99,277,621	RGD:6480464	CTD
G	CYP3A5	cytochrome P450, family 3, subfamily A, polypeptide 5		increases metabolic processing	EXP	7	99,245,813	99,277,621	RGD:6480464	CTD
G	CYP3A5	cytochrome P450, family 3, subfamily A, polypeptide 5		multiple interactions	EXP	7	99,245,813	99,277,621	RGD:6480464	CTD
G	CYP8B1	cytochrome P450, family 8, subfamily B, polypeptide 1		increases response to substance	EXP	3	42,913,684	42,917,633	RGD:6480464	CTD
G	DAZ1	deleted in azoospermia 1		increases response to substance	EXP	Y	25,275,502	25,345,239	RGD:6480464	CTD
G	DAZ3	deleted in azoospermia 3		increases response to substance	EXP	Y	26,909,216	26,959,639	RGD:6480464	CTD
G	DAZ4	deleted in azoospermia 4		increases response to substance	EXP	Y	26,979,967	27,053,187	RGD:6480464	CTD
G	DDX52	DEAD (Asp-Glu-Ala-Asp) box polypeptide 52		increases response to substance	EXP	17	35,972,363	36,003,493	RGD:6480464	CTD
G	DOK2	docking protein 2, 56kDa		increases response to substance	EXP	8	21,766,384	21,771,205	RGD:6480464	CTD
G	DPYD	dihydropyrimidine dehydrogenase		increases response to substance	EXP	1	97,543,299	98,386,615	RGD:6480464	CTD
G	EDNRB	endothelin receptor type B		increases expression	ISO	13 13	78,469,616 78,513,393	78,549,664 78,549,674	RGD:6480464	CTD
G	EGR1	early growth response 1		increases expression	EXP	5	137,801,181	137,805,004	RGD:6480464	CTD
G	ELOVL6	ELOVL fatty acid elongase 6		increases response to substance	EXP	4	110,970,229	111,119,820	RGD:6480464	CTD
G	EPHX1	epoxide hydrolase 1, microsomal (xenobiotic)		increases response to substance	EXP	1	225,997,797	226,033,264	RGD:6480464	CTD
G	EPHX1	epoxide hydrolase 1, microsomal (xenobiotic)		decreases expression	ISO	1	225,997,797	226,033,264	RGD:6480464	CTD
G	EPRS	glutamyl-prolyl-tRNA synthetase		increases expression	ISO	1	220,141,942	220,220,000	RGD:6480464	CTD
G	ERBB2	v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)		increases response to substance	EXP	17	37,844,393	37,884,915	RGD:6480464	CTD
G	ERCC2	excision repair cross-complementing rodent repair deficiency, complementation group 2		increases response to substance	EXP	19	45,854,649	45,873,845	RGD:6480464	CTD
G	ESM1	endothelial cell-specific molecule 1		decreases expression	ISO	5	54,273,695	54,281,414	RGD:6480464	CTD
G	EXO1	exonuclease 1		increases response to substance	EXP	1	242,011,493	242,053,241	RGD:6480464	CTD
G	F2	coagulation factor II (thrombin)		affects expression	EXP	11	46,740,743	46,761,056	RGD:6480464	CTD
G	F3	coagulation factor III (thromboplastin, tissue factor)		increases expression	EXP	1	94,994,732	95,007,413	RGD:6480464	CTD
G	F3	coagulation factor III (thromboplastin, tissue factor)		increases expression	ISO	1	94,994,732	95,007,413	RGD:6480464	CTD
G	FAM126A	family with sequence similarity 126, member A		increases response to substance	EXP	7	22,980,878	23,053,770	RGD:6480464	CTD
G	FANCI	Fanconi anemia, complementation group I		increases response to substance	EXP	15	89,787,194	89,860,362	RGD:6480464	CTD
G	FASLG	Fas ligand (TNF superfamily, member 6)		increases expression	EXP	1	172,628,185	172,636,013	RGD:6480464	CTD
G	FCGR2B	Fc fragment of IgG, low affinity IIb, receptor (CD32)		increases expression	ISO	1	161,632,905	161,648,444	RGD:6480464	CTD
G	FCGR2C	Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)		increases response to substance	EXP	1	161,551,129	161,571,010	RGD:6480464	CTD
G	FGFR4	fibroblast growth factor receptor 4		increases response to substance	EXP	5	176,513,921	176,525,127	RGD:6480464	CTD
G	FIG4	FIG4 homolog, SAC1 lipid phosphatase domain containing (S. cerevisiae)		increases response to substance	EXP	6	110,012,424	110,146,634	RGD:6480464	CTD
G	FOS	FBJ murine osteosarcoma viral oncogene homolog		increases expression	ISO	14	75,745,481	75,748,937	RGD:6480464	CTD
G	FUT6	fucosyltransferase 6 (alpha (1,3) fucosyltransferase)		increases response to substance	EXP	19	5,830,637	5,839,742	RGD:6480464	CTD
G	GADD45A	growth arrest and DNA-damage-inducible, alpha		increases expression	ISO	1	68,150,860	68,154,021	RGD:6480464	CTD
G	GADD45B	growth arrest and DNA-damage-inducible, beta		increases expression	ISO	19	2,476,123	2,478,257	RGD:6480464	CTD
G	GADD45G	growth arrest and DNA-damage-inducible, gamma		increases expression	ISO	9	92,219,927	92,221,470	RGD:6480464	CTD
G	GAGE12I	G antigen 12I		increases response to substance	EXP	X	49,216,677	49,223,943	RGD:6480464	CTD
G	GAGE2C	G antigen 2C		increases response to substance	EXP	X	49,226,171	49,233,491	RGD:6480464	CTD
G	GAGE3	G antigen 3		increases response to substance	EXP				RGD:6480464	CTD
G	GAGE4	G antigen 4		increases response to substance	EXP	X	49,103,593	49,110,884	RGD:6480464	CTD
G	GAGE6	G antigen 6		increases response to substance	EXP	X	49,212,424	49,219,752	RGD:6480464	CTD
G	GAGE7	G antigen 7		increases response to substance	EXP	X	49,103,622	49,110,884	RGD:6480464	CTD
G	GAS7	growth arrest-specific 7		decreases expression	ISO	17	9,813,926	10,101,868	RGD:6480464	CTD
G	GCLC	glutamate-cysteine ligase, catalytic subunit		multiple interactions	EXP	6	53,362,139	53,409,927	RGD:6480464	CTD
G	GCLM	glutamate-cysteine ligase, modifier subunit		multiple interactions	EXP	1	94,352,590	94,375,012	RGD:6480464	CTD
G	GET4	golgi to ER traffic protein 4 homolog (S. cerevisiae)		increases response to substance	EXP	7	916,191	936,071	RGD:6480464	CTD
G	GHR	growth hormone receptor		increases response to substance	EXP	5	42,423,877	42,721,980	RGD:6480464	CTD
G	GLI1	GLI family zinc finger 1		increases response to substance	EXP	12	57,853,918	57,866,051	RGD:6480464	CTD
G	GPR15	G protein-coupled receptor 15		increases response to substance	EXP	3	98,250,878	98,251,960	RGD:6480464	CTD
G	GPX1	glutathione peroxidase 1		increases response to substance	EXP	3	49,394,609	49,395,791	RGD:6480464	CTD
G	GSTM1	glutathione S-transferase mu 1		affects response to substance	EXP	1	110,230,418	110,236,367	RGD:6480464	CTD
G	GSTM1	glutathione S-transferase mu 1		decreases response to substance	EXP	1	110,230,418	110,236,367	RGD:6480464	CTD
G	GSTM1	glutathione S-transferase mu 1		multiple interactions	EXP	1	110,230,418	110,236,367	RGD:6480464	CTD
G	GSTP1	glutathione S-transferase pi 1		increases response to substance	EXP	11	67,351,066	67,354,124	RGD:6480464	CTD
G	GSTP1	glutathione S-transferase pi 1		multiple interactions	EXP	11	67,351,066	67,354,124	RGD:6480464	CTD
G	GSTP1	glutathione S-transferase pi 1		decreases response to substance	EXP	11	67,351,066	67,354,124	RGD:6480464	CTD
G	GSTZ1	glutathione S-transferase zeta 1		increases response to substance	EXP	14	77,787,230	77,797,940	RGD:6480464	CTD
G	GTF2H1	general transcription factor IIH, polypeptide 1, 62kDa		increases response to substance	EXP	11	18,343,816	18,388,590	RGD:6480464	CTD
G	HBBP1	hemoglobin, beta pseudogene 1		increases response to substance	EXP	11	5,263,184	5,264,822	RGD:6480464	CTD
G	HELQ	helicase, POLQ-like		increases response to substance	EXP	4	84,328,499	84,377,025	RGD:6480464	CTD
G	HERPUD1	homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1		increases response to substance	EXP	16	56,965,748	56,977,793	RGD:6480464	CTD
G	HMMR	hyaluronan-mediated motility receptor (RHAMM)		increases response to substance	EXP	5	162,887,517	162,918,951	RGD:6480464	CTD
G	HMOX1	heme oxygenase (decycling) 1		increases expression	ISO	22	35,777,060	35,790,207	RGD:6480464	CTD
G	HRAS	v-Ha-ras Harvey rat sarcoma viral oncogene homolog		increases expression	EXP	11	532,242	535,550	RGD:6480464	CTD
G	HSPB2	heat shock 27kDa protein 2		decreases response to substance	EXP	11	111,783,460	111,784,817	RGD:6480464	CTD
G	HTR2A	5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled		multiple interactions	ISO	13	47,405,677	47,471,211	RGD:6480464	CTD
G	HTR2A	5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled		increases expression	ISO	13	47,405,677	47,471,211	RGD:6480464	CTD
G	ICAM1	intercellular adhesion molecule 1		increases expression	ISO	19	10,381,517	10,397,291	RGD:6480464	CTD
G	ID3	inhibitor of DNA binding 3, dominant negative helix-loop-helix protein		increases response to substance	EXP	1	23,884,421	23,886,285	RGD:6480464	CTD
G	ID3	inhibitor of DNA binding 3, dominant negative helix-loop-helix protein		increases response to substance	EXP	1	23,884,421	23,886,285	RGD:6480464	CTD
G	IFI44	interferon-induced protein 44		increases response to substance	EXP	1	79,115,477	79,129,763	RGD:6480464	CTD
G	IFNA1	interferon, alpha 1		increases response to substance	EXP	9	21,440,453	21,441,315	RGD:6480464	CTD
G	IGF1	insulin-like growth factor 1 (somatomedin C)		multiple interactions	EXP	12	102,789,645	102,874,378	RGD:6480464	CTD
G	IGF1	insulin-like growth factor 1 (somatomedin C)		decreases response to substance	ISO	12	102,789,645	102,874,378	RGD:6480464	CTD
G	IGF2BP3	insulin-like growth factor 2 mRNA binding protein 3		increases response to substance	EXP	7	23,349,828	23,509,995	RGD:6480464	CTD
G	IGHG1	immunoglobulin heavy constant gamma 1 (G1m marker)		increases response to substance	EXP				RGD:6480464	CTD
G	IGHMBP2	immunoglobulin mu binding protein 2		increases response to substance	EXP	11	68,671,319	68,708,069	RGD:6480464	CTD
G	IL1B	interleukin 1, beta		increases expression	ISO	2	113,587,337	113,594,356	RGD:6480464	CTD
G	IL6	interleukin 6 (interferon, beta 2)		increases expression	EXP	7	22,766,766	22,771,621	RGD:6480464	CTD
G	IL6	interleukin 6 (interferon, beta 2)		increases expression	ISO	7	22,766,766	22,771,621	RGD:6480464	CTD
G	IL6	interleukin 6 (interferon, beta 2)		affects response to substance	ISO	7	22,766,766	22,771,621	RGD:6480464	CTD
G	INA	internexin neuronal intermediate filament protein, alpha		multiple interactions	EXP	10	105,036,920	105,050,108	RGD:6480464	CTD
G	INHA	inhibin, alpha		decreases expression	ISO	2	220,436,954	220,440,435	RGD:6480464	CTD
G	ITM2A	integral membrane protein 2A		decreases response to substance	EXP	X	78,615,881	78,623,049	RGD:6480464	CTD
G	JUN	jun proto-oncogene		increases response to substance	EXP	1	59,246,463	59,249,785	RGD:6480464	CTD
G	KCNA5	potassium voltage-gated channel, shaker-related subfamily, member 5		increases response to substance	EXP	12	5,153,085	5,155,954	RGD:6480464	CTD
G	KMT2B	lysine (K)-specific methyltransferase 2B		increases response to substance	EXP	19	36,208,921	36,229,779	RGD:6480464	CTD
G	LAIR2	leukocyte-associated immunoglobulin-like receptor 2		increases response to substance	EXP	19	55,014,013	55,021,900	RGD:6480464	CTD
G	LILRB1	leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1		increases response to substance	EXP	19	55,128,629	55,149,007	RGD:6480464	CTD
G	LILRB4	leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4		increases response to substance	EXP	19	55,174,124	55,179,848	RGD:6480464	CTD
G	LRP5	low density lipoprotein receptor-related protein 5		increases response to substance	EXP	11	68,080,108	68,216,743	RGD:6480464	CTD
G	LTA	lymphotoxin alpha (TNF superfamily, member 1)		increases response to substance	EXP	6	31,539,876	31,542,101	RGD:6480464	CTD
G	MAGEA2	melanoma antigen family A, 2		increases response to substance	EXP	X	151,918,388	151,922,364	RGD:6480464	CTD
G	MAGEA2B	melanoma antigen family A, 2B		increases response to substance	EXP	X	151,885,384	151,887,080	RGD:6480464	CTD
G	MAPKBP1	mitogen-activated protein kinase binding protein 1		increases response to substance	EXP	15	42,066,632	42,120,053	RGD:6480464	CTD
G	MAPRE1	microtubule-associated protein, RP/EB family, member 1		multiple interactions	EXP	20	31,407,699	31,438,211	RGD:6480464	CTD
G	MAPRE1	microtubule-associated protein, RP/EB family, member 1		decreases localization	EXP	20	31,407,699	31,438,211	RGD:6480464	CTD
G	MAPRE3	microtubule-associated protein, RP/EB family, member 3		affects localization	EXP	2	27,193,525	27,250,087	RGD:6480464	CTD
G	MAPRE3	microtubule-associated protein, RP/EB family, member 3		multiple interactions	EXP	2	27,193,525	27,250,087	RGD:6480464	CTD
G	MBL2	mannose-binding lectin (protein C) 2, soluble		increases response to substance	EXP	10	54,525,140	54,531,460	RGD:6480464	CTD
G	MDM2	MDM2 oncogene, E3 ubiquitin protein ligase		decreases expression	EXP	12	69,201,971	69,239,320	RGD:6480464	CTD
G	MFSD6	major facilitator superfamily domain containing 6		decreases response to substance	EXP	2	191,273,081	191,367,041	RGD:6480464	CTD
G	MGMT	O-6-methylguanine-DNA methyltransferase		increases response to substance	EXP	10	131,265,454	131,565,783	RGD:6480464	CTD
G	MGMT	O-6-methylguanine-DNA methyltransferase		multiple interactions	EXP	10	131,265,454	131,565,783	RGD:6480464	CTD
G	MGMT	O-6-methylguanine-DNA methyltransferase		multiple interactions	EXP	10	131,265,454	131,565,783	RGD:6480464	CTD
G	MGMT	O-6-methylguanine-DNA methyltransferase		multiple interactions	EXP	10	131,265,454	131,565,783	RGD:6480464	CTD
G	MIAT	myocardial infarction associated transcript (non-protein coding)		increases response to substance	EXP	22	27,053,446	27,072,441	RGD:6480464	CTD
G	MIR497	microRNA 497		multiple interactions	EXP	17	6,921,230	6,921,341	RGD:6480464	CTD
G	MKI67	antigen identified by monoclonal antibody Ki-67		increases response to substance	EXP	10	129,894,923	129,924,468	RGD:6480464	CTD
G	MPZ	myelin protein zero		increases response to substance	ISO	1	161,274,525	161,279,762	RGD:6480464	CTD
G	MTR	5-methyltetrahydrofolate-homocysteine methyltransferase		increases response to substance	EXP	1	236,958,581	237,067,281	RGD:6480464	CTD
G	MUTYH	mutY homolog (E. coli)		increases response to substance	EXP	1	45,794,914	45,806,142	RGD:6480464	CTD
G	MYC	v-myc myelocytomatosis viral oncogene homolog (avian)		increases expression	ISO	8	128,748,315	128,753,680	RGD:6480464	CTD
G	MYC	v-myc myelocytomatosis viral oncogene homolog (avian)		decreases expression	EXP	8	128,748,315	128,753,680	RGD:6480464	CTD
G	MYCN	v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)		multiple interactions	EXP	2	16,080,683	16,087,129	RGD:6480464	CTD
G	MYCN	v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)		decreases response to substance	EXP	2	16,080,683	16,087,129	RGD:6480464	CTD
G	MYO3A	myosin IIIA		increases response to substance	EXP	10	26,223,002	26,501,465	RGD:6480464	CTD
G	NAT1	N-acetyltransferase 1 (arylamine N-acetyltransferase)		increases response to substance	EXP	8	18,027,971	18,081,198	RGD:6480464	CTD
G	NBN	nibrin		increases expression	ISO	8	90,945,564	90,996,899	RGD:6480464	CTD
G	NFATC2	nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2		increases response to substance	EXP	20	50,003,494	50,179,370	RGD:6480464	CTD
G	NGF	nerve growth factor (beta polypeptide)		multiple interactions	ISO	1	115,828,537	115,880,857	RGD:6480464	CTD
G	NGF	nerve growth factor (beta polypeptide)		decreases response to substance	ISO	1	115,828,537	115,880,857	RGD:6480464	CTD
G	NGF	nerve growth factor (beta polypeptide)		decreases response to substance	ISO	1	115,828,537	115,880,857	RGD:6480464	CTD
G	NGF	nerve growth factor (beta polypeptide)		decreases response to substance	ISO	1	115,828,537	115,880,857	RGD:6480464	CTD
G	NGF	nerve growth factor (beta polypeptide)		decreases response to substance	ISO	1	115,828,537	115,880,857	RGD:6480464	CTD
G	NMNAT3	nicotinamide nucleotide adenylyltransferase 3		decreases response to substance	ISO	3	139,279,022	139,396,885	RGD:6480464	CTD
G	NOS1	nitric oxide synthase 1 (neuronal)		decreases expression	ISO	12	117,645,947	117,799,607	RGD:6480464	CTD
G	NPC2	Niemann-Pick disease, type C2		increases response to substance	EXP	14	74,946,643	74,960,084	RGD:6480464	CTD
G	NR1I2	nuclear receptor subfamily 1, group I, member 2		multiple interactions	EXP	3	119,499,331	119,537,332	RGD:6480464	CTD
G	NR1I2	nuclear receptor subfamily 1, group I, member 2		increases activity	EXP	3	119,499,331	119,537,332	RGD:6480464	CTD
G	NRP1	neuropilin 1		increases response to substance	EXP	10	33,466,419	33,623,833	RGD:6480464	CTD
G	OSBPL6	oxysterol binding protein-like 6		increases response to substance	EXP	2	179,059,208	179,264,160	RGD:6480464	CTD
G	OSGEP	O-sialoglycoprotein endopeptidase		increases response to substance	EXP	14	20,915,207	20,923,267	RGD:6480464	CTD
G	P2RX7	purinergic receptor P2X, ligand-gated ion channel, 7		multiple interactions	ISO	12	121,570,622	121,624,354	RGD:6480464	CTD
G	PAGE1	P antigen family, member 1 (prostate associated)		increases response to substance	EXP	X	49,452,053	49,460,596	RGD:6480464	CTD
G	PARP1	poly (ADP-ribose) polymerase 1		increases response to substance	EXP	1	226,548,392	226,595,801	RGD:6480464	CTD
G	PASK	PAS domain containing serine/threonine kinase		increases response to substance	EXP	2	242,045,514	242,089,394	RGD:6480464	CTD
G	PLAT	plasminogen activator, tissue		increases expression	ISO	8	42,032,236	42,065,194	RGD:6480464	CTD
G	PLAUR	plasminogen activator, urokinase receptor		increases expression	ISO	19	44,150,247	44,174,498	RGD:6480464	CTD
G	PLEKHG4	pleckstrin homology domain containing, family G (with RhoGef domain) member 4		increases response to substance	EXP	16	67,311,413	67,323,403	RGD:6480464	CTD
G	PLXDC2	plexin domain containing 2		increases response to substance	EXP	10	20,105,372	20,569,115	RGD:6480464	CTD
G	PMP22	peripheral myelin protein 22		increases response to substance	EXP	17	15,133,096	15,168,644	RGD:6480464	CTD
G	POLB	polymerase (DNA directed), beta		increases response to substance	EXP	8	42,195,973	42,229,331	RGD:6480464	CTD
G	POLG	polymerase (DNA directed), gamma		increases response to substance	EXP	15	89,859,536	89,878,026	RGD:6480464	CTD
G	PON2	paraoxonase 2		increases response to substance	EXP	7	95,034,174	95,064,384	RGD:6480464	CTD
G	PPARD	peroxisome proliferator-activated receptor delta		increases response to substance	EXP	6	35,310,335	35,395,968	RGD:6480464	CTD
G	PPP1R15A	protein phosphatase 1, regulatory subunit 15A		increases expression	ISO	19	49,375,649	49,379,319	RGD:6480464	CTD
G	PPP1R1B	protein phosphatase 1, regulatory (inhibitor) subunit 1B		increases response to substance	EXP	17	37,783,177	37,792,878	RGD:6480464	CTD
G	PRC1	protein regulator of cytokinesis 1		increases expression	EXP	15	91,509,268	91,537,881	RGD:6480464	CTD
G	PRKCE	protein kinase C, epsilon		increases response to substance	ISO	2	45,879,043	46,415,129	RGD:6480464	CTD
G	PRNP	prion protein		decreases response to substance	EXP	20	4,666,797	4,682,234	RGD:6480464	CTD
G	PRX	periaxin		increases response to substance	EXP	19	40,899,671	40,919,271	RGD:6480464	CTD
G	PSMB7	proteasome (prosome, macropain) subunit, beta type, 7		increases response to substance	EXP	9	127,115,744	127,177,752	RGD:6480464	CTD
G	PTGIS	prostaglandin I2 (prostacyclin) synthase		increases response to substance	EXP	20	48,120,411	48,184,707	RGD:6480464	CTD
G	PTGS1	prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)		increases response to substance	EXP	9	125,132,809	125,157,982	RGD:6480464	CTD
G	PTK2B	protein tyrosine kinase 2 beta		increases phosphorylation	EXP	8	27,168,999	27,316,908	RGD:6480464	CTD
G	PTPN13	protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)		increases response to substance	EXP	4	87,515,468	87,736,329	RGD:6480464	CTD
G	QRICH1	glutamine-rich 1		increases phosphorylation	EXP	3	49,067,142	49,131,504	RGD:6480464	CTD
G	RAC2	ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)		affects response to substance	ISO	22	37,621,310	37,640,305	RGD:6480464	CTD
G	RASSF1	Ras association (RalGDS/AF-6) domain family member 1		increases expression	ISO	3	50,367,217	50,378,367	RGD:6480464	CTD
G	RBM17	RNA binding motif protein 17		decreases response to substance	EXP	10	6,130,949	6,159,422	RGD:6480464	CTD
G	RBMY2FP	RNA binding motif protein, Y-linked, family 2, member F pseudogene		increases response to substance	EXP	Y	24,455,004	24,462,352	RGD:6480464	CTD
G	RGS10	regulator of G-protein signaling 10		increases response to substance	EXP	10	121,259,339	121,302,222	RGD:6480464	CTD
G	RGS17	regulator of G-protein signaling 17		increases response to substance	EXP	6	153,332,026	153,452,389	RGD:6480464	CTD
G	RORA	RAR-related orphan receptor A		increases response to substance	EXP	15	60,780,483	61,521,502	RGD:6480464	CTD
G	RPL6	ribosomal protein L6		decreases response to substance	EXP	12	112,842,994	112,847,443	RGD:6480464	CTD
G	RRM1	ribonucleotide reductase M1		increases response to substance	EXP	11	4,115,924	4,160,106	RGD:6480464	CTD
G	RUNX3	runt-related transcription factor 3		increases response to substance	EXP	1	25,226,002	25,291,501	RGD:6480464	CTD
G	S100A8	S100 calcium binding protein A8		increases expression	ISO	1	153,362,508	153,363,664	RGD:6480464	CTD
G	S100A9	S100 calcium binding protein A9		increases expression	ISO	1	153,330,330	153,333,503	RGD:6480464	CTD
G	SCARB1	scavenger receptor class B, member 1		increases response to substance	EXP	12	125,262,174	125,348,519	RGD:6480464	CTD
G	SELE	selectin E		increases response to substance	EXP	1	169,691,781	169,703,220	RGD:6480464	CTD
G	SELE	selectin E		increases expression	ISO	1	169,691,781	169,703,220	RGD:6480464	CTD
G	SERPINB2	serpin peptidase inhibitor, clade B (ovalbumin), member 2		increases response to substance	EXP	18	61,554,939	61,571,124	RGD:6480464	CTD
G	SERPINE1	serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1		increases response to substance	EXP	7	100,770,370	100,782,547	RGD:6480464	CTD
G	SERPINE1	serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1		increases expression	ISO	7	100,770,370	100,782,547	RGD:6480464	CTD
G	SESN1	sestrin 1		increases expression	ISO	6	109,307,640	109,415,708	RGD:6480464	CTD
G	SGCA	sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein)		increases response to substance	EXP	17	48,243,366	48,253,293	RGD:6480464	CTD
G	SHFM1	split hand/foot malformation (ectrodactyly) type 1		increases response to substance	EXP	7	96,318,079	96,339,203	RGD:6480464	CTD
G	SIM1	single-minded homolog 1 (Drosophila)		increases response to substance	EXP	6	100,836,750	100,911,551	RGD:6480464	CTD
G	SLC10A2	solute carrier family 10 (sodium/bile acid cotransporter family), member 2		increases response to substance	EXP	13	103,696,348	103,719,196	RGD:6480464	CTD
G	SLC10A2	solute carrier family 10 (sodium/bile acid cotransporter family), member 2		increases response to substance	EXP	13	103,696,348	103,719,196	RGD:6480464	CTD
G	SLC12A6	solute carrier family 12 (potassium/chloride transporters), member 6		increases response to substance	EXP	15	34,522,197	34,630,265	RGD:6480464	CTD
G	SLC22A5	solute carrier family 22 (organic cation/carnitine transporter), member 5		increases response to substance	EXP	5	131,705,401	131,731,306	RGD:6480464	CTD
G	SLC28A1	solute carrier family 28 (sodium-coupled nucleoside transporter), member 1		increases response to substance	EXP	15	85,427,913	85,489,027	RGD:6480464	CTD
G	SLC2A1	solute carrier family 2 (facilitated glucose transporter), member 1		decreases response to substance	EXP	1	43,391,046	43,424,847	RGD:6480464	CTD
G	SLCO3A1	solute carrier organic anion transporter family, member 3A1		increases response to substance	EXP	15	92,396,938	92,715,665	RGD:6480464	CTD
G	SMC2	structural maintenance of chromosomes 2		increases response to substance	EXP	9	106,856,541	106,903,700	RGD:6480464	CTD
G	SOD3	superoxide dismutase 3, extracellular		increases response to substance	EXP	4	24,797,085	24,802,467	RGD:6480464	CTD
G	SOS1	son of sevenless homolog 1 (Drosophila)		increases expression	EXP	2	39,208,690	39,347,604	RGD:6480464	CTD
G	SPDL1	spindle apparatus coiled-coil protein 1		increases response to substance	EXP	5	169,010,638	169,031,782	RGD:6480464	CTD
G	SPON1	spondin 1, extracellular matrix protein		increases expression	ISO	11	13,984,184	14,289,679	RGD:6480464	CTD
G	SRD5A2	steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)		increases response to substance	EXP	2	31,749,656	31,806,040	RGD:6480464	CTD
G	SRI	sorcin		decreases response to substance	EXP	7	87,834,432	87,856,308	RGD:6480464	CTD
G	SSX1	synovial sarcoma, X breakpoint 1		increases response to substance	EXP	X	48,114,797	48,126,879	RGD:6480464	CTD
G	SSX2	synovial sarcoma, X breakpoint 2		increases response to substance	EXP	X	52,725,946	52,736,249	RGD:6480464	CTD
G	SSX4	synovial sarcoma, X breakpoint 4		increases response to substance	EXP	X	48,242,968	48,252,785	RGD:6480464	CTD
G	SSX4B	synovial sarcoma, X breakpoint 4B		increases response to substance	EXP	X	48,261,524	48,271,355	RGD:6480464	CTD
G	STAT1	signal transducer and activator of transcription 1, 91kDa		increases expression	EXP	2	191,833,762	191,878,976	RGD:6480464	CTD
G	SULT2B1	sulfotransferase family, cytosolic, 2B, member 1		increases response to substance	EXP	19	49,055,429	49,102,684	RGD:6480464	CTD
G	SVOP	SV2 related protein homolog (rat)		increases response to substance	EXP	12	109,304,658	109,372,453	RGD:6480464	CTD
G	TCFL5	transcription factor-like 5 (basic helix-loop-helix)		increases response to substance	EXP	20	61,472,467	61,493,115	RGD:6480464	CTD
G	THBS1	thrombospondin 1		increases expression	ISO	15	39,873,280	39,889,668	RGD:6480464	CTD
G	TIMP1	TIMP metallopeptidase inhibitor 1		increases expression	ISO	X	47,441,690	47,446,190	RGD:6480464	CTD
G	TLN2	talin 2		increases response to substance	EXP	15	62,939,510	63,136,830	RGD:6480464	CTD
G	TMED5	transmembrane emp24 protein transport domain containing 5		decreases response to substance	EXP	1	93,615,299	93,646,246	RGD:6480464	CTD
G	TMEM98	transmembrane protein 98		increases response to substance	EXP	17	31,254,928	31,268,667	RGD:6480464	CTD
G	TNFSF8	tumor necrosis factor (ligand) superfamily, member 8		increases response to substance	EXP	9	117,655,623	117,692,875	RGD:6480464	CTD
G	TNNI3	troponin I type 3 (cardiac)		increases expression	ISO	19	55,663,135	55,669,100	RGD:6480464	CTD
G	TP53	tumor protein p53		increases response to substance	EXP	17	7,571,720	7,590,868	RGD:6480464	CTD
G	TP53	tumor protein p53		increases glutathionylation	EXP	17	7,571,720	7,590,868	RGD:6480464	CTD
G	TP53	tumor protein p53		increases expression	EXP	17	7,571,720	7,590,868	RGD:6480464	CTD
G	TP53	tumor protein p53		increases expression	EXP	17	7,571,720	7,590,868	RGD:6480464	CTD
G	TPD52L1	tumor protein D52-like 1		increases expression	ISO	6	125,474,879	125,584,644	RGD:6480464	CTD
G	TPI1	triosephosphate isomerase 1		affects response to substance	EXP	12	6,976,584	6,980,110	RGD:6480464	CTD
G	TPO	thyroid peroxidase		increases response to substance	EXP	2	1,417,233	1,546,499	RGD:6480464	CTD
G	TPP1	tripeptidyl peptidase I		increases response to substance	EXP	11	6,633,997	6,640,692	RGD:6480464	CTD
G	TRPC4	transient receptor potential cation channel, subfamily C, member 4		increases response to substance	EXP	13	38,210,773	38,443,939	RGD:6480464	CTD
G	TRPV4	transient receptor potential cation channel, subfamily V, member 4		increases response to substance	ISO	12	110,220,892	110,271,212	RGD:6480464	CTD
G	TSG101	tumor susceptibility gene 101		affects response to substance	EXP	11	18,501,858	18,548,503	RGD:6480464	CTD
G	TSPO	translocator protein (18kDa)		increases response to substance	EXP	22	43,547,520	43,559,248	RGD:6480464	CTD
G	TUBA1B	tubulin, alpha 1b		decreases expression	ISO	12	49,521,565	49,525,304	RGD:6480464	CTD
G	TUBA4A	tubulin, alpha 4a		decreases expression	ISO	2	220,115,001	220,118,638	RGD:6480464	CTD
G	TUBB	tubulin, beta class I		decreases expression	ISO	6	30,688,157	30,693,199	RGD:6480464	CTD
G	TUBB4B	tubulin, beta 4B class IVb		decreases expression	ISO	9	140,135,711	140,138,159	RGD:6480464	CTD
G	TUBG1	tubulin, gamma 1		decreases expression	ISO	17	40,761,358	40,767,256	RGD:6480464	CTD
G	TWF1	twinfilin actin-binding protein 1		affects response to substance	ISO	12	44,187,526	44,200,178	RGD:6480464	CTD
G	TYMP	thymidine phosphorylase		multiple interactions	EXP	22	50,964,181	50,968,514	RGD:6480464	CTD
G	TYMS	thymidylate synthetase		affects response to substance	EXP	18	657,604	673,499	RGD:6480464	CTD
G	UCHL1	ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)		increases expression	ISO	4	41,258,898	41,270,446	RGD:6480464	CTD
G	UCP1	uncoupling protein 1 (mitochondrial, proton carrier)		increases response to substance	EXP	4	141,481,050	141,489,959	RGD:6480464	CTD
G	UGT2B7	UDP glucuronosyltransferase 2 family, polypeptide B7		increases response to substance	EXP	4	69,962,193	69,978,705	RGD:6480464	CTD
G	UNC13C	unc-13 homolog C (C. elegans)		increases response to substance	EXP	15	54,305,101	54,920,806	RGD:6480464	CTD
G	UPK3A	uroplakin 3A		increases response to substance	EXP	22	45,680,868	45,691,755	RGD:6480464	CTD
G	UTP20	UTP20, small subunit (SSU) processome component, homolog (yeast)		increases response to substance	EXP	12	101,673,905	101,780,397	RGD:6480464	CTD
G	VCAM1	vascular cell adhesion molecule 1		increases expression	ISO	1	101,185,196	101,204,601	RGD:6480464	CTD
G	VDR	vitamin D (1,25- dihydroxyvitamin D3) receptor		affects response to substance	EXP	12	48,235,320	48,298,814	RGD:6480464	CTD
G	VEGFA	vascular endothelial growth factor A		decreases expression	ISO	6	43,737,946	43,754,224	RGD:6480464	CTD
G	VWF	von Willebrand factor		increases expression	ISO	12	6,058,040	6,233,836	RGD:6480464	CTD
G	WNT11	wingless-type MMTV integration site family, member 11		increases response to substance	EXP	11	75,897,370	75,917,574	RGD:6480464	CTD
G	YPEL5	yippee-like 5 (Drosophila)		decreases response to substance	EXP	2	30,369,750	30,383,399	RGD:6480464	CTD
G	ZNF596	zinc finger protein 596		increases response to substance	EXP	8	182,200	197,339	RGD:6480464	CTD
G	ZNRD1	zinc ribbon domain containing 1		multiple interactions	EXP	6	30,029,036	30,032,686	RGD:6480464	CTD
G	ZNRD1	zinc ribbon domain containing 1		decreases response to substance	EXP	6	30,029,036	30,032,686	RGD:6480464	CTD
vindesine
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	BAX	BCL2-associated X protein		multiple interactions	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		decreases expression	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		increases expression	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	NGF	nerve growth factor (beta polypeptide)		decreases response to substance	ISO	1	115,828,537	115,880,857	RGD:6480464	CTD

Term paths to the root

Path 1
Term	Annotations
CHEBI ontology	523433
chemical entity	523433
atom	522326
nonmetal atom	478827
carbon atom	432855
organic molecular entity	432848
organic fundamental parent	125902
natural product fundamental parent	42703
alkaloid fundamental parent	2161
indole alkaloid fundamental parent	865
vincaleukoblastine	671
vincaleukoblastine sulfate	0
vincristine	370
vindesine +	5
Path 2
Term	Annotations
CHEBI ontology	523433
subatomic particle	522326
composite particle	522326
hadron	522326
baryon	522326
nucleon	522326
atomic nucleus	522326
atom	522326
main group element atom	490114
p-block element atom	487514
carbon group element atom	436485
carbon atom	432855
organic molecular entity	432848
heteroorganic entity	345036
organonitrogen compound	159724
alkaloid	9971
indole alkaloid	2021
terpenoid indole alkaloid	1019
monoterpenoid indole alkaloid	996
vinca alkaloid	691
vincaleukoblastine	671
vincaleukoblastine sulfate	0
vincristine	370
vindesine +	5